Skip to content
Screener

10x Genomics, Inc. TXG Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

TEC
Bio-TechneTECH
$90.32M-3.4%
Agilent Technologies logo
Agilent TechnologiesA
$187M-1.1%
Quanterix Corporation logo
Quanterix CorporationQTRX
$35.34M-2.9%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$174.8M+4.3%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$439.87M-5.9%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$85.36M+49.8%

Other financials

Income statement

See full
Revenue$151.0M-12.6%
Gross profit$112.5M-10.1%
Operating income-$19.6M-165%
Net income-$17.9M-152%
EPS (diluted)-$0.14-150%

Balance sheet

See full
Cash & equivalents$502.5M+26.4%
Total debt$78.8M-9.2%
Total equity$825.5M+6.8%
Total assets$1.0B+5.1%

Cash flow

See full
Operating cash flow$17.0M-4.1%
CapEx$1.6M+0.6%
Free cash flow$15.4M-4.6%

Valuation

See full
Market cap$5.79B+271%
Enterprise value$5.37B+330%
P/S9.4×+7.0×

Profitability

See full
Gross margin70%+0.5pp
Operating margin-14.3%-1.1pp
Net margin-12.2%-0.8pp
FCF margin19.7%+10.9pp

Returns & leverage

See full
Return on equity-9.4%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.7×-0.1×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054491
Year Ended December 31,Operating Leases
20309,827
Thereafter29,449
Total lease payments$95,038
Less: imputed interest(16,242)
Present value of operating lease liabilities$78,796
Operating lease liabilities, current$12,015
Operating lease liabilities, noncurrent66,781
Total operating lease liabilities$78,796

Item 1. Financial Statements (Unaudited)

FAQ

What is 10x Genomics, Inc.'s operating lease liabilities (total)?
10x Genomics, Inc. (TXG) reported operating lease liabilities (total) of $78.8M in Q2 2026.
How has 10x Genomics, Inc.'s operating lease liabilities (total) changed year-over-year?
10x Genomics, Inc.'s operating lease liabilities (total) decreased by 9.2% year-over-year, from $86.74M to $78.8M.
What is the long-term trend for 10x Genomics, Inc.'s operating lease liabilities (total)?
Over 5 years (2020 to 2025), 10x Genomics, Inc.'s operating lease liabilities (total) has grown at a 6.0% compound annual growth rate (CAGR), from $62.98M to $84.36M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.

Ask your AI about 10x Genomics, Inc.'s operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude